348 research outputs found
Prostanoids in bronchoalveolar lavage fluid do not predict outcome in congenital diaphragmatic hernia patients
Vasoactive prostanoids may be involved in persistent pulmonary hypertension (PPH) in infants with a congenital diaphragmatic hernia (CDH). We hypothesized that increased levels of prostanoids in bronchoalveolar lavage (BAL) fluid would predict clinical outcome. We measured the concentrations of 6-keto-prostaglandin F1α (6-keto-PGF1α), thromboxane B2 (TxB2), protein, albumin, total cell count, and elastase-α1-proteinase-inhibitor complex in BAL fluid of 18 CDH patients and of 13 control subjects without PPH. We found different concentrations of prostanoids in BAL fluid of CDH patients with PPH: infants with a poor prognosis had either high levels of both 6-keto-PGF1α and TxB2 compared to controls, or high levels of
6-keto-PGF1α only. TxB2 levels showed a large variability in all CDH patients irrespective of outcome. We conclude that prostanoid levels in BAL fluid do not predict clinical outcome in CDH patients
Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children
BACKGROUND: Descriptions of the pharmacokinetics and metabolism of
morphine and its metabolites in young children are scant. Previous studies
have not differentiated the effects of size from those related to age
during infancy. METHODS: Postoperative children 0-3 yr old were given an
intravenous loading dose of morphine hydrochloride (100 micro g kg(-1) in
2 min) followed by either an intravenous morphine infusion of 10 micro g
h(-1) kg(-1) (n=92) or 3-hourly intravenous morphine boluses of 30 micro g
kg(-1) (n=92). Additional morphine (5 micro g kg(-1)) every 10 min was
given if the visual analogue (VAS, 0-10) pain score was >/=4. Arterial
blood (1.4 ml) was sampled within 5 min of the loading dose and at 6, 12
and 24 h for morphine, morphine-3-glucuronide (M3G) and
morphine-6-glucuronide (M6G). The disposition of morphine and formation
clearances of morphine base to its glucuronide metabolites and their
elimination clearances were estimated using non-linear mixed effects
models. RESULTS: The analysis used 1856 concentration observations from
184 subjects. Population parameter estimates and their variability (%) for
a one-compartment, first-order elimination model were as follows: volume
of distribution 136 (59.3) litres, formation clearance to M3G 64.3 (58.8)
litres h(-1), formation clearance to M6G 3.63 (82.2) litres h(-1),
morphine clearance by other routes 3.12 litres h(-1) per 70 kg,
elimination clearance of M3G 17.4 (43.0) litres h(-1), elimination
clearance of M6G 5.8 (73.8) litres h(-1). All parameters are standardized
to a 70 kg person using allometric 3/4 power models and reflect fully
mature adult values. The volume of distribution increased exponentially
with a maturation half-life of 26 days from 83 litres per 70 kg at birth;
formation clearance to M3G and M6G increased with a maturation half-life
of 88.3 days from 10.8 and 0.61 litres h(-1) per 70 kg respectively at
birth. Metabolite formation decreased with increased serum bilirubin
concentration. Metabolite clearance increased with age (maturation
half-life 129 days), and appeared to be similar to that described for
glomerular filtration rate maturation in infants. CONCLUSION: M3G is the
predominant metabolite of morphine in young children and total body
morphine clearance is 80% that of adult values by 6 months. A mean
steady-state serum concentration of 10 ng ml(-1) can be achieved in
children after non-cardiac surgery in an intensive care unit with a
morphine hydrochloride infusion of 5 micro g h(-1) kg(-1) at birth (term
neonates), 8.5 micro g h(-1) kg(-1) at 1 month, 13.5 micro g h(-1) kg(-1)
at 3 months and 18 micro g h(-1) kg(-1) at 1 year and 16 micro g h(-1)
kg(-1) for 1- to 3-yr-old children
The vulnerable microcirculation in the critically ill pediatric patient
In neonates, cardiovascular system development does not stop after the transition from intra-uterine to extra-uterine life and is not limited to the macrocirculation. The microcirculation (MC), which is essential for oxygen, nutrient, and drug delivery to tissues and cells, also develops. Developmental changes in the microcirculatory structure continue to occur during the initial weeks of life in healthy neonates. The physiologic hallmarks of neonates and developing children make them particularly vulnerable during critical illness; however, the cardiovascular monitoring possibilities are limited compared with critically ill adult patients. Therefore, the development of non-invasive methods for monitoring the MC is necessary in pediatric critical care for early identification of impending deterioration and to enable the initiation and titration of therapy to ensure cell survival. To date, the MC may be non-invasively monitored at the bedside using hand-held videomicroscopy, which provides useful information regarding the microcirculation. There is an increasing number of studies on the MC in neonates and pediatric patients; however, additional steps are necessary to transition MC monitoring from bench to bedside. The recently introduced concept of hemodynamic coherence describes the relationship between changes in the MC and macrocirculation. The loss of hemodynamic coherence may result in a depressed MC despite an improvement in the macrocirculation, which represents a condition associated with adverse outcomes. In the pediatric intensive care unit, the concept of hemodynamic coherence may function as a framework to develop microcirculatory measurements towards implementation in daily clinical practice
Lung eicosanoids in perinatal rats with congenital diaphragmatic hernia
Abnormal levels of pulmonary eicosanoids have been reported in infants with persistent pulmonary hypertension (PPH) and congenital diaphragmatic hernia (CDH). We hypothesized that a dysbalance of vasoconstrictive and vasodilatory eicosanoids is involved in PPH in CDH patients. The levels of several eicosanoids in lung homogenates and in bronchoalveolar lavage fluid of controls and rats with CDH were measured after caesarean section or spontaneous birth. In controls the concentration of the stable metabolite of prostacyclin (6-keto-PGF1α), thromboxane
A2 (TxB2), prostaglandin E2 (PGE2), and leukotriene B4 (LTB4) decreased after spontaneous birth. CDH pups showed respiratory insufficiency directly after birth. Their lungs had higher levels of 6- keto-PGF1α, reflecting the pulmonary vasodilator prostacyclin
(PGI2), than those of controls. We conclude that in CDH abnormal lung eicosanoid levels are present perinatally. The elevated levels of 6-keto-PGF1α in CDH may reflect a compensation mechanism for increased vascular resistance
Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals
Background: This position statement provides clinical recommendations for the assessment of pain, level of sedation, iatrogenic withdrawal syndrome and delirium in critically ill infants and children. Admission to a neonatal or paediatric intensive care unit (NICU, PICU) exposes a child to a series of painful and stressful events. Accurate assessment of the presence of pain and non-pain related distress (adequacy of sedation, iatrogenic withdrawal syndrome, and delirium) is essential to good clinical management and to monitoring the effectiveness of interventions to relieve or prevent pain and distress in the individual patient.
Methods: A multidisciplinary group of experts was recruited from the members of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC). The group formulated clinical questions regarding assessment of pain and non-pain related distress in critically ill and non-verbal children, and searched the PubMed/Medline, Cinahl, and Embase databases for studies describing the psychometric properties of assessment instruments. Further, level of evidence of selected studies was assigned and recommendations were formulated, and grade or recommendations were added based on the level of evidence.
Results: An ESPNIC Position Statement was drafted which provides clinical recommendations on assessment of pain (n=5), distress and/or level of sedation (n=4), iatrogenic withdrawal syndrome (n=3), and delirium (n=3). These recommendations were based on the available evidence and consensus amongst the experts and other members of the ESPNIC society.
Conclusions: This multidisciplinary ESPNIC Position Statement guides professionals in the assessment and re-assessment of the effectiveness of treatment interventions for pain, distress, inadequate sedation, withdrawal syndrome and delirium
Haemofiltration in newborns treated with extracorporeal membrane oxygenation: a case-comparison study
Introduction: Extracorporeal membrane oxygenation is a supportive cardiopulmonary bypass technique for patients with acute reversible cardiovascular or respiratory failure. Favourable effects of haemofiltration during cardiopulmonary bypass instigated the use of this technique in infants on extracorporeal membrane oxygenation. The current study aimed at comparing clinical outcomes of newborns on extracorporeal membrane oxygenation with and without continuous haemofiltration. Methods: Demographic data of newborns treated with haemofiltration during extracorporeal membrane oxygenation were compared with those of patients treated without haemofiltration in a retrospective 1:3 case-comparison study. Primary outcome parameters were time on extracorporeal membrane oxygenation, time until extubation after decannulation, mortality and potential cost reduction. Secondary outcome parameters were total and mean fluid balance, urine output in mL/kg/day, dose of vasopressors, blood products and fluid bolus infusions, serum creatinin, urea and albumin levels. Results: Fifteen patients with haemof
Long-term pulmonary sequelae in children with congenital diaphragmatic hernia.
Neonates with congenital diaphragmatic hernia (CDH) often suffer from respiratory
insufficiency due to lung hypoplasia and pulmonary hypertension. Artificial
ventilation is frequently required, and this leads to a high incidence of
bronchopulmonary dysplasia. Long-term follow-up studies have shown persisting
airway obstruction. To evaluate the long-term pulmonary sequelae in CDH, we
studied 40 CDH patients of age 7 to 18 yr (median 11.7 yr) and 65 age-matched
controls without CDH and lung hypoplasia who underwent similar neonatal
treatment. Mild airway obstruction was found in both groups with more peripheral
airway obstruction in CDH patients than in control subjects. Both groups had
normal TLC and single-breath carbon monoxide diffusion capacity (DLCO). CDH
patients had increased residual volume (RV) and RV/TLC compared with controls.
Increased airway responsiveness to methacholine (MCH) was common but
bronchoconstriction to inhaled metabisulfite (MBS) was rare both in CDH and
control subjects. We conclude that this group of CDH patients has minor residual
lung function impairment. Mild airway obstruction and increased airway
responsiveness to inhaled MCH but not to MBS suggest that structural changes in
distal airways are involved and not autonomic nerve dysfunction. Both artificial
ventilation in the neonatal period and residual lung hypoplasia seem important
determinants of persistent lung function abnormalities in CDH patients
Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infants
BACKGROUND: To investigate clinical variables such as gestational age,
sex, weight, the therapeutic regimens used and mechanical ventilation that
might affect morphine requirements and plasma concentrations of morphine
and its metabolites. METHODS: In a double-blind study, neonates and
infants stratified for age [group I 0-4 weeks (neonates), group II > or
=4-26 weeks, group III > or =26-52 weeks, group IV > or =1-3 yr] admitted
to the paediatric intensive care unit after abdominal or thoracic surgery
received morphine 100 micro g kg(-1) after surgery, and were randomly
assigned to either continuous morphine 10 micro g kg(-1) h(-1) or
intermittent morphine boluses 30 micro g kg(-1) every 3 h. Pain was
measured using the COMFORT behavioural scale and a visual analogue scale.
Additional morphine was adm
Feasibility of sedation and analgesia interruption following cannulation in neonates on extracorporeal membrane oxygenation
Purpose: In most extracorporeal membrane oxygenation (ECMO) centers patients are heavily sedated to prevent accidental decannulation and bleeding complications. In ventilated adults not on ECMO, daily sedation interruption protocols improve short- and long-term outcome. This study aims to evaluate safety and feasibility of sedation interruption following cannulation in neonates on ECMO. Methods: Prospective observational study in 20 neonates (0.17-5.8 days of age) admitted for ECMO treatment. Midazolam (n = 20) and morphine (n = 18) infusions were discontinued within 30 min after cannulation. Pain and sedation were regularly assessed using COMFORT-B and visual analog scale (VAS) scores. Midazolam and/or morphine were restarted and titrated according to protocolized treatment algorithms. Results: Median (interquartile range, IQR) time without any sedatives was 10.3 h (5.0-24.1 h). Median interruption duration for midazolam was 16.5 h (6.6-29.6 h), and for morphine was 11.2 h (6.7-39.4 h). During this period no accidental extubations, decannulations or bleeding complications occurred. Conclusions: This is the first study to show that interruption of sedatives and analgesics following cannulation in neonates on ECMO is safe and feasible. Interruption times are 2-3 times longer than reported for adult ICU patients not on ECMO. Further trials are needed to substantiate these findings and evaluate short- and long-term outcomes
The occurrence of adverse events in low-risk non-survivors in pediatric intensive care patients: an exploratory study
We studied the occurrence of adverse events (AEs) in low-risk non-survivors (LNs), compared to low-risk survivors (LSs), high-risk non-survivors (HNs), and high-risk survivors (HSs) in two pediatric intensive care units (PICUs). The study was performed as a retrospective patient record review study, using a PICU-trigger tool. A random sample of 48 PICU patients (0–18 years) was chosen, stratified into four subgroups of 12 patients: LNs, LSs, HNs, and HSs. Primary outcome was the occurrence of AEs. The severity, preventability, and nature of the indentified AEs were determined. In total, 45 AEs were found in 20 patients. The occurrence of AEs in the LN group was significantly higher compared to that in the LS group and HN group (AE occurrence: LN 10/12 patients, LS 1/12 patients; HN 2/12 patients; HS 7/12 patients; LN-LS difference, p < 0.001; LN-HN difference, p < 0.01). The AE rate in the LN group was significantly higher compared to that in the LS and HN groups (median [IQR]: LN 0.12 [0.07–0.29], LS 0 [0–0], HN 0 [0–0], and HS 0.03 [0.0–0.17] AE/PICU day; LN-LS difference, p < 0.001; LN-HN difference, p < 0.01). The distribution of the AEs among the four groups was as follows: 25 AEs (LN), 2 AEs (LS), 8 AEs (HN), and 10 AEs (HS). Fifteen of forty-five AEs were preventable. In 2/12 LN patients, death occurred after a preventable AE. Conclusion: The occurrence of AEs in LNs was higher compared to that in LSs and HNs. Some AEs were severe and preventable and contributed to mortality.(Table presented.
- …